APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antimicrobial Peptides

Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.

Selected research

Market Analysis & Forecast

Global Antimicrobial Peptides Market Analysis and Forecast 2026-2032

1 January 2026195 pages

Choose your research edition.

Industry ResearchAntimicrobial Peptides Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Antimicrobial Peptides Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Antimicrobial Peptides Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antimicrobial Peptides Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Antimicrobial Peptides Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.

The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019.

By region, North America had the highest share of sales, at about 35%.

Read the full market overview

This report presents an overview of global market for Antimicrobial Peptides, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Antimicrobial Peptides, also provides the sales of main regions and countries. Of the upcoming market potential for Antimicrobial Peptides, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antimicrobial Peptides sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Antimicrobial Peptides market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Antimicrobial Peptides sales, projected growth trends, production technology, application and end-user industry.

Antimicrobial Peptides Segment by Company

AnaSpec

AMP Biotech

Phoenix Biotech

Novabiotics

Chinese Peptide

Ontores

GenScript

Hycult Biotech

Sunsmile

Ruixing Biotechnology

Zhongnong Yingtai Biotechnology

Glam Technology

ProteLight Pharmaceutical & Biotechnology

Antimicrobial Peptides Segment by Type

Plant Antimicrobial Peptides

Microbial Antimicrobial Peptides

Animal Antimicrobial Peptides

Antimicrobial Peptides Segment by Application

Pharmaceuticals

Feed Additives

Others

Antimicrobial Peptides Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antimicrobial Peptides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antimicrobial Peptides and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antimicrobial Peptides.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Antimicrobial Peptides in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Antimicrobial Peptides manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antimicrobial Peptides sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Antimicrobial Peptides Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Plant Antimicrobial Peptides Major Manufacturers Table 3. Microbial Antimicrobial Peptides Major Manufacturers Table 4. Animal Antimicrobial Peptides Major Manufacturers Table 5. Global Antimicrobial Peptides Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Pharmaceuticals Major Manufacturers Table 7. Feed Additives Major Manufacturers Table 8. Others Major Manufacturers Table 9. Antimicrobial Peptides Industry Trends Table 10. Antimicrobial Peptides Industry Drivers Table 11. Antimicrobial Peptides Industry Opportunities and Challenges Table 12. Antimicrobial Peptides Industry Restraints Table 13. Global Antimicrobial Peptides Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Antimicrobial Peptides Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Antimicrobial Peptides Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Antimicrobial Peptides Revenue Market Share by Region (2021-2026) Table 17. Global Antimicrobial Peptides Revenue Market Share by Region (2027-2032) Table 18. Global Antimicrobial Peptides Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Mg) Table 19. Global Antimicrobial Peptides Sales by Region (2021-2026) & (Mg) Table 20. Global Antimicrobial Peptides Sales by Region (2027-2032) & (Mg) Table 21. Global Antimicrobial Peptides Sales Market Share by Region (2021-2026) Table 22. Global Antimicrobial Peptides Sales Market Share by Region (2027-2032) Table 23. Global Antimicrobial Peptides Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Antimicrobial Peptides Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Antimicrobial Peptides Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Antimicrobial Peptides Sales Market Share by Manufacturers (2021-2026) Table 27. Global Antimicrobial Peptides Sales Price (US$/Mg) of Manufacturers (2021-2026) Table 28. Global Antimicrobial Peptides Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Antimicrobial Peptides Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Antimicrobial Peptides Manufacturers, Product Type & Application Table 31. Global Antimicrobial Peptides Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Antimicrobial Peptides by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Antimicrobial Peptides Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Antimicrobial Peptides Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Antimicrobial Peptides Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Antimicrobial Peptides Revenue Market Share by Type (2021-2026) Table 38. Global Antimicrobial Peptides Revenue Market Share by Type (2027-2032) Table 39. Global Antimicrobial Peptides Sales by Type 2021 VS 2025 VS 2032 (Mg) Table 40. Global Antimicrobial Peptides Sales by Type (2021-2026) & (Mg) Table 41. Global Antimicrobial Peptides Sales by Type (2027-2032) & (Mg) Table 42. Global Antimicrobial Peptides Sales Market Share by Type (2021-2026) Table 43. Global Antimicrobial Peptides Sales Market Share by Type (2027-2032) Table 44. Global Antimicrobial Peptides Price by Type (2021-2026) & (US$/Mg) Table 45. Global Antimicrobial Peptides Price by Type (2027-2032) & (US$/Mg) Table 46. Global Antimicrobial Peptides Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Antimicrobial Peptides Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Antimicrobial Peptides Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Antimicrobial Peptides Revenue Market Share by Application (2021-2026) Table 50. Global Antimicrobial Peptides Revenue Market Share by Application (2027-2032) Table 51. Global Antimicrobial Peptides Sales by Application 2021 VS 2025 VS 2032 (Mg) Table 52. Global Antimicrobial Peptides Sales by Application (2021-2026) & (Mg) Table 53. Global Antimicrobial Peptides Sales by Application (2027-2032) & (Mg) Table 54. Global Antimicrobial Peptides Sales Market Share by Application (2021-2026) Table 55. Global Antimicrobial Peptides Sales Market Share by Application (2027-2032) Table 56. Global Antimicrobial Peptides Price by Application (2021-2026) & (US$/Mg) Table 57. Global Antimicrobial Peptides Price by Application (2027-2032) & (US$/Mg) Table 58. AnaSpec Company Information Table 59. AnaSpec Business Overview Table 60. AnaSpec Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 61. AnaSpec Antimicrobial Peptides Product Portfolio Table 62. AnaSpec Recent Development Table 63. AMP Biotech Company Information Table 64. AMP Biotech Business Overview Table 65. AMP Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 66. AMP Biotech Antimicrobial Peptides Product Portfolio Table 67. AMP Biotech Recent Development Table 68. Phoenix Biotech Company Information Table 69. Phoenix Biotech Business Overview Table 70. Phoenix Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 71. Phoenix Biotech Antimicrobial Peptides Product Portfolio Table 72. Phoenix Biotech Recent Development Table 73. Novabiotics Company Information Table 74. Novabiotics Business Overview Table 75. Novabiotics Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 76. Novabiotics Antimicrobial Peptides Product Portfolio Table 77. Novabiotics Recent Development Table 78. Chinese Peptide Company Information Table 79. Chinese Peptide Business Overview Table 80. Chinese Peptide Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 81. Chinese Peptide Antimicrobial Peptides Product Portfolio Table 82. Chinese Peptide Recent Development Table 83. Ontores Company Information Table 84. Ontores Business Overview Table 85. Ontores Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 86. Ontores Antimicrobial Peptides Product Portfolio Table 87. Ontores Recent Development Table 88. GenScript Company Information Table 89. GenScript Business Overview Table 90. GenScript Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 91. GenScript Antimicrobial Peptides Product Portfolio Table 92. GenScript Recent Development Table 93. Hycult Biotech Company Information Table 94. Hycult Biotech Business Overview Table 95. Hycult Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 96. Hycult Biotech Antimicrobial Peptides Product Portfolio Table 97. Hycult Biotech Recent Development Table 98. Sunsmile Company Information Table 99. Sunsmile Business Overview Table 100. Sunsmile Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 101. Sunsmile Antimicrobial Peptides Product Portfolio Table 102. Sunsmile Recent Development Table 103. Ruixing Biotechnology Company Information Table 104. Ruixing Biotechnology Business Overview Table 105. Ruixing Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 106. Ruixing Biotechnology Antimicrobial Peptides Product Portfolio Table 107. Ruixing Biotechnology Recent Development Table 108. Zhongnong Yingtai Biotechnology Company Information Table 109. Zhongnong Yingtai Biotechnology Business Overview Table 110. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 111. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product Portfolio Table 112. Zhongnong Yingtai Biotechnology Recent Development Table 113. Glam Technology Company Information Table 114. Glam Technology Business Overview Table 115. Glam Technology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 116. Glam Technology Antimicrobial Peptides Product Portfolio Table 117. Glam Technology Recent Development Table 118. ProteLight Pharmaceutical & Biotechnology Company Information Table 119. ProteLight Pharmaceutical & Biotechnology Business Overview Table 120. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 121. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product Portfolio Table 122. ProteLight Pharmaceutical & Biotechnology Recent Development Table 123. North America Antimicrobial Peptides Revenue by Type (2021-2026) & (US$ Million) Table 124. North America Antimicrobial Peptides Revenue by Type (2027-2032) & (US$ Million) Table 125. North America Antimicrobial Peptides Sales by Type (2021-2026) & (Mg) Table 126. North America Antimicrobial Peptides Sales by Type (2027-2032) & (Mg) Table 127. North America Antimicrobial Peptides Sales Price by Type (2021-2026) & (US$/Mg) Table 128. North America Antimicrobial Peptides Sales Price by Type (2027-2032) & (US$/Mg) Table 129. North America Antimicrobial Peptides Revenue by Application (2021-2026) & (US$ Million) Table 130. North America Antimicrobial Peptides Revenue by Application (2027-2032) & (US$ Million) Table 131. North America Antimicrobial Peptides Sales by Application (2021-2026) & (Mg) Table 132. North America Antimicrobial Peptides Sales by Application (2027-2032) & (Mg) Table 133. North America Antimicrobial Peptides Sales Price by Application (2021-2026) & (US$/Mg) Table 134. North America Antimicrobial Peptides Sales Price by Application (2027-2032) & (US$/Mg) Table 135. North America Antimicrobial Peptides Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. North America Antimicrobial Peptides Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 137. North America Antimicrobial Peptides Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 138. North America Antimicrobial Peptides Sales by Country (2021 VS 2025 VS 2032) & (Mg) Table 139. North America Antimicrobial Peptides Sales by Country (2021-2026) & (Mg) Table 140. North America Antimicrobial Peptides Sales by Country (2027-2032) & (Mg) Table 141. North America Antimicrobial Peptides Sales Price by Country (2021-2026) & (US$/Mg) Table 142. North America Antimicrobial Peptides Sales Price by Country (2027-2032) & (US$/Mg) Table 143. United States Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 144. Canada Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 145. Mexico Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 146. Europe Antimicrobial Peptides Revenue by Type (2021-2026) & (US$ Million) Table 147. Europe Antimicrobial Peptides Revenue by Type (2027-2032) & (US$ Million) Table 148. Europe Antimicrobial Peptides Sales by Type (2021-2026) & (Mg) Table 149. Europe Antimicrobial Peptides Sales by Type (2027-2032) & (Mg) Table 150. Europe Antimicrobial Peptides Sales Price by Type (2021-2026) & (US$/Mg) Table 151. Europe Antimicrobial Peptides Sales Price by Type (2027-2032) & (US$/Mg) Table 152. Europe Antimicrobial Peptides Revenue by Application (2021-2026) & (US$ Million) Table 153. Europe Antimicrobial Peptides Revenue by Application (2027-2032) & (US$ Million) Table 154. Europe Antimicrobial Peptides Sales by Application (2021-2026) & (Mg) Table 155. Europe Antimicrobial Peptides Sales by Application (2027-2032) & (Mg) Table 156. Europe Antimicrobial Peptides Sales Price by Application (2021-2026) & (US$/Mg) Table 157. Europe Antimicrobial Peptides Sales Price by Application (2027-2032) & (US$/Mg) Table 158. Europe Antimicrobial Peptides Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Europe Antimicrobial Peptides Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Europe Antimicrobial Peptides Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Europe Antimicrobial Peptides Sales by Country (2021 VS 2025 VS 2032) & (Mg) Table 162. Europe Antimicrobial Peptides Sales by Country (2021-2026) & (Mg) Table 163. Europe Antimicrobial Peptides Sales by Country (2027-2032) & (Mg) Table 164. Europe Antimicrobial Peptides Sales Price by Country (2021-2026) & (US$/Mg) Table 165. Europe Antimicrobial Peptides Sales Price by Country (2027-2032) & (US$/Mg) Table 166. Germany Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 167. France Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 168. U.K. Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 169. Italy Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 170. Russia Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 171. Spain Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 172. Netherlands Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 173. Switzerland Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 174. Sweden Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 175. Poland Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 176. China Antimicrobial Peptides Revenue by Type (2021-2026) & (US$ Million) Table 177. China Antimicrobial Peptides Revenue by Type (2027-2032) & (US$ Million) Table 178. China Antimicrobial Peptides Sales by Type (2021-2026) & (Mg) Table 179. China Antimicrobial Peptides Sales by Type (2027-2032) & (Mg) Table 180. China Antimicrobial Peptides Sales Price by Type (2021-2026) & (US$/Mg) Table 181. China Antimicrobial Peptides Sales Price by Type (2027-2032) & (US$/Mg) Table 182. China Antimicrobial Peptides Revenue by Application (2021-2026) & (US$ Million) Table 183. China Antimicrobial Peptides Revenue by Application (2027-2032) & (US$ Million) Table 184. China Antimicrobial Peptides Sales by Application (2021-2026) & (Mg) Table 185. China Antimicrobial Peptides Sales by Application (2027-2032) & (Mg) Table 186. China Antimicrobial Peptides Sales Price by Application (2021-2026) & (US$/Mg) Table 187. China Antimicrobial Peptides Sales Price by Application (2027-2032) & (US$/Mg) Table 188. Asia Antimicrobial Peptides Revenue by Type (2021-2026) & (US$ Million) Table 189. Asia Antimicrobial Peptides Revenue by Type (2027-2032) & (US$ Million) Table 190. Asia Antimicrobial Peptides Sales by Type (2021-2026) & (Mg) Table 191. Asia Antimicrobial Peptides Sales by Type (2027-2032) & (Mg) Table 192. Asia Antimicrobial Peptides Sales Price by Type (2021-2026) & (US$/Mg) Table 193. Asia Antimicrobial Peptides Sales Price by Type (2027-2032) & (US$/Mg) Table 194. Asia Antimicrobial Peptides Revenue by Application (2021-2026) & (US$ Million) Table 195. Asia Antimicrobial Peptides Revenue by Application (2027-2032) & (US$ Million) Table 196. Asia Antimicrobial Peptides Sales by Application (2021-2026) & (Mg) Table 197. Asia Antimicrobial Peptides Sales by Application (2027-2032) & (Mg) Table 198. Asia Antimicrobial Peptides Sales Price by Application (2021-2026) & (US$/Mg) Table 199. Asia Antimicrobial Peptides Sales Price by Application (2027-2032) & (US$/Mg) Table 200. Asia Antimicrobial Peptides Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 201. Asia Antimicrobial Peptides Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 202. Asia Antimicrobial Peptides Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 203. Asia Antimicrobial Peptides Sales by Country (2021 VS 2025 VS 2032) & (Mg) Table 204. Asia Antimicrobial Peptides Sales by Country (2021-2026) & (Mg) Table 205. Asia Antimicrobial Peptides Sales by Country (2027-2032) & (Mg) Table 206. Asia Antimicrobial Peptides Sales Price by Country (2021-2026) & (US$/Mg) Table 207. Asia Antimicrobial Peptides Sales Price by Country (2027-2032) & (US$/Mg) Table 208. Japan Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 209. South Korea Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 210. India Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 211. Australia Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 212. Taiwan Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 213. Southeast Asia Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 214. SAMEA Antimicrobial Peptides Revenue by Type (2021-2026) & (US$ Million) Table 215. SAMEA Antimicrobial Peptides Revenue by Type (2027-2032) & (US$ Million) Table 216. SAMEA Antimicrobial Peptides Sales by Type (2021-2026) & (Mg) Table 217. SAMEA Antimicrobial Peptides Sales by Type (2027-2032) & (Mg) Table 218. SAMEA Antimicrobial Peptides Sales Price by Type (2021-2026) & (US$/Mg) Table 219. SAMEA Antimicrobial Peptides Sales Price by Type (2027-2032) & (US$/Mg) Table 220. SAMEA Antimicrobial Peptides Revenue by Application (2021-2026) & (US$ Million) Table 221. SAMEA Antimicrobial Peptides Revenue by Application (2027-2032) & (US$ Million) Table 222. SAMEA Antimicrobial Peptides Sales by Application (2021-2026) & (Mg) Table 223. SAMEA Antimicrobial Peptides Sales by Application (2027-2032) & (Mg) Table 224. SAMEA Antimicrobial Peptides Sales Price by Application (2021-2026) & (US$/Mg) Table 225. SAMEA Antimicrobial Peptides Sales Price by Application (2027-2032) & (US$/Mg) Table 226. SAMEA Antimicrobial Peptides Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 227. SAMEA Antimicrobial Peptides Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 228. SAMEA Antimicrobial Peptides Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 229. SAMEA Antimicrobial Peptides Sales by Country (2021 VS 2025 VS 2032) & (Mg) Table 230. SAMEA Antimicrobial Peptides Sales by Country (2021-2026) & (Mg) Table 231. SAMEA Antimicrobial Peptides Sales by Country (2027-2032) & (Mg) Table 232. SAMEA Antimicrobial Peptides Sales Price by Country (2021-2026) & (US$/Mg) Table 233. SAMEA Antimicrobial Peptides Sales Price by Country (2027-2032) & (US$/Mg) Table 234. Brazil Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 235. Argentina Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 236. Chile Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 237. Colombia Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 238. Peru Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 239. Saudi Arabia Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 240. Israel Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 241. UAE Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 242. Turkey Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 243. Iran Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 244. Egypt Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Table 245. Key Raw Materials Table 246. Raw Materials Key Suppliers Table 247. Antimicrobial Peptides Distributors List Table 248. Antimicrobial Peptides Customers List Table 249. Research Programs/Design for This Report Table 250. Authors List of This Report Table 251. Secondary Sources Table 252. Primary Sources List of Figures Figure 1. Antimicrobial Peptides Image Figure 2. Global Antimicrobial Peptides Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antimicrobial Peptides Market Size Share 2021 VS 2025 VS 2032 Figure 4. Plant Antimicrobial Peptides Image Figure 5. Microbial Antimicrobial Peptides Image Figure 6. Animal Antimicrobial Peptides Image Figure 7. Global Antimicrobial Peptides Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Antimicrobial Peptides Market Size Share 2021 VS 2025 VS 2032 Figure 9. Pharmaceuticals Image Figure 10. Feed Additives Image Figure 11. Others Image Figure 12. Global Antimicrobial Peptides Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Antimicrobial Peptides Revenue (2021-2032) & (US$ Million) Figure 14. Global Antimicrobial Peptides Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Antimicrobial Peptides Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Antimicrobial Peptides Revenue Market Share by Region (2021-2032) Figure 17. Global Antimicrobial Peptides Sales (2021-2032) & (Mg) Figure 18. Global Antimicrobial Peptides Sales by Region: 2021 VS 2025 VS 2032 (Mg) Figure 19. Global Antimicrobial Peptides Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Antimicrobial Peptides Sales YoY (2021-2032) & (Mg) Figure 21. Europe Antimicrobial Peptides Sales YoY (2021-2032) & (Mg) Figure 22. China Antimicrobial Peptides Sales YoY (2021-2032) & (Mg) Figure 23. Asia (Excluding China) Antimicrobial Peptides Sales YoY (2021-2032) & (Mg) Figure 24. South America, Middle East and Africa Antimicrobial Peptides Sales YoY (2021-2032) & (Mg) Figure 25. Global Antimicrobial Peptides Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Antimicrobial Peptides Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Antimicrobial Peptides Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Antimicrobial Peptides Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Antimicrobial Peptides Revenue Market Share by Type (2021-2032) Figure 31. Global Antimicrobial Peptides Sales by Type (2021 VS 2025 VS 2032) & (Mg) Figure 32. Global Antimicrobial Peptides Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Antimicrobial Peptides Sales Market Share by Type (2021-2032) Figure 34. Global Antimicrobial Peptides Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Antimicrobial Peptides Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Antimicrobial Peptides Revenue Market Share by Application (2021-2032) Figure 37. Global Antimicrobial Peptides Sales by Application (2021 VS 2025 VS 2032) & (Mg) Figure 38. Global Antimicrobial Peptides Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Antimicrobial Peptides Sales Market Share by Application (2021-2032) Figure 40. North America Antimicrobial Peptides Revenue Share by Type (2021-2032) Figure 41. North America Antimicrobial Peptides Sales Share by Type (2021-2032) Figure 42. North America Antimicrobial Peptides Revenue Share by Application (2021-2032) Figure 43. North America Antimicrobial Peptides Sales Share by Application (2021-2032) Figure 44. North America Antimicrobial Peptides Revenue Share by Country (2021-2032) Figure 45. North America Antimicrobial Peptides Sales Share by Country (2021-2032) Figure 46. Europe Antimicrobial Peptides Revenue Share by Type (2021-2032) Figure 47. Europe Antimicrobial Peptides Sales Share by Type (2021-2032) Figure 48. Europe Antimicrobial Peptides Revenue Share by Application (2021-2032) Figure 49. Europe Antimicrobial Peptides Sales Share by Application (2021-2032) Figure 50. Europe Antimicrobial Peptides Revenue Share by Country (2021-2032) Figure 51. Europe Antimicrobial Peptides Sales Share by Country (2021-2032) Figure 52. China Antimicrobial Peptides Revenue Share by Type (2021-2032) Figure 53. China Antimicrobial Peptides Sales Share by Type (2021-2032) Figure 54. China Antimicrobial Peptides Revenue Share by Application (2021-2032) Figure 55. China Antimicrobial Peptides Sales Share by Application (2021-2032) Figure 56. Asia Antimicrobial Peptides Revenue Share by Type (2021-2032) Figure 57. Asia Antimicrobial Peptides Sales Share by Type (2021-2032) Figure 58. Asia Antimicrobial Peptides Revenue Share by Application (2021-2032) Figure 59. Asia Antimicrobial Peptides Sales Share by Application (2021-2032) Figure 60. Asia Antimicrobial Peptides Revenue Share by Country (2021-2032) Figure 61. Asia Antimicrobial Peptides Sales Share by Country (2021-2032) Figure 62. SAMEA Antimicrobial Peptides Revenue Share by Type (2021-2032) Figure 63. SAMEA Antimicrobial Peptides Sales Share by Type (2021-2032) Figure 64. SAMEA Antimicrobial Peptides Revenue Share by Application (2021-2032) Figure 65. SAMEA Antimicrobial Peptides Sales Share by Application (2021-2032) Figure 66. SAMEA Antimicrobial Peptides Revenue Share by Country (2021-2032) Figure 67. SAMEA Antimicrobial Peptides Sales Share by Country (2021-2032) Figure 68. Antimicrobial Peptides Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Antimicrobial Peptides Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Plant Antimicrobial Peptides
  • Microbial Antimicrobial Peptides
  • Animal Antimicrobial Peptides
Applications
  • Pharmaceuticals
  • Feed Additives
  • Others
Companies covered
  • AnaSpec
  • AMP Biotech
  • Phoenix Biotech
  • Novabiotics
  • Chinese Peptide
  • Ontores
  • GenScript
  • Hycult Biotech
  • Sunsmile
  • Ruixing Biotechnology
  • Zhongnong Yingtai Biotechnology
  • Glam Technology
  • ProteLight Pharmaceutical & Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Antimicrobial Peptides Market by Type
  3. 1.2.1 Global Antimicrobial Peptides Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Plant Antimicrobial Peptides
  5. 1.2.3 Microbial Antimicrobial Peptides
  6. 1.2.4 Animal Antimicrobial Peptides
  7. 1.3 Antimicrobial Peptides Market by Application
  8. 1.3.1 Global Antimicrobial Peptides Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Pharmaceuticals
  10. 1.3.3 Feed Additives
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Antimicrobial Peptides Market Dynamics
  1. 2.1 Antimicrobial Peptides Industry Trends
  2. 2.2 Antimicrobial Peptides Industry Drivers
  3. 2.3 Antimicrobial Peptides Industry Opportunities and Challenges
  4. 2.4 Antimicrobial Peptides Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Antimicrobial Peptides Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Antimicrobial Peptides Revenue by Region
  3. 3.2.1 Global Antimicrobial Peptides Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Antimicrobial Peptides Revenue by Region (2021-2026)
  5. 3.2.3 Global Antimicrobial Peptides Revenue by Region (2027-2032)
  6. 3.2.4 Global Antimicrobial Peptides Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Antimicrobial Peptides Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Antimicrobial Peptides Sales by Region
  9. 3.4.1 Global Antimicrobial Peptides Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Antimicrobial Peptides Sales by Region (2021-2026)
  11. 3.4.3 Global Antimicrobial Peptides Sales by Region (2027-2032)
  12. 3.4.4 Global Antimicrobial Peptides Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Antimicrobial Peptides Revenue by Manufacturers
  2. 4.1.1 Global Antimicrobial Peptides Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Antimicrobial Peptides Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Antimicrobial Peptides Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Antimicrobial Peptides Sales by Manufacturers
  6. 4.2.1 Global Antimicrobial Peptides Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Antimicrobial Peptides Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Antimicrobial Peptides Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Antimicrobial Peptides Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Antimicrobial Peptides Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Antimicrobial Peptides Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Antimicrobial Peptides Manufacturers, Product Type & Application
  13. 4.7 Global Antimicrobial Peptides Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Antimicrobial Peptides Market CR5 and HHI
  16. 4.8.2 2025 Antimicrobial Peptides Tier 1, Tier 2, and Tier 3
5 Antimicrobial Peptides Market by Type
  1. 5.1 Global Antimicrobial Peptides Revenue by Type
  2. 5.1.1 Global Antimicrobial Peptides Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Antimicrobial Peptides Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Antimicrobial Peptides Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Antimicrobial Peptides Sales by Type
  6. 5.2.1 Global Antimicrobial Peptides Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Antimicrobial Peptides Sales by Type (2021-2032) & (Mg)
  8. 5.2.3 Global Antimicrobial Peptides Sales Market Share by Type (2021-2032)
  9. 5.3 Global Antimicrobial Peptides Price by Type
6 Antimicrobial Peptides Market by Application
  1. 6.1 Global Antimicrobial Peptides Revenue by Application
  2. 6.1.1 Global Antimicrobial Peptides Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Antimicrobial Peptides Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Antimicrobial Peptides Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Antimicrobial Peptides Sales by Application
  6. 6.2.1 Global Antimicrobial Peptides Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Antimicrobial Peptides Sales by Application (2021-2032) & (Mg)
  8. 6.2.3 Global Antimicrobial Peptides Sales Market Share by Application (2021-2032)
  9. 6.3 Global Antimicrobial Peptides Price by Application
7 Company Profiles
  1. 7.1 AnaSpec
  2. 7.1.1 AnaSpec Company Information
  3. 7.1.2 AnaSpec Business Overview
  4. 7.1.3 AnaSpec Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 AnaSpec Antimicrobial Peptides Product Portfolio
  6. 7.1.5 AnaSpec Recent Developments
  7. 7.2 AMP Biotech
  8. 7.2.1 AMP Biotech Company Information
  9. 7.2.2 AMP Biotech Business Overview
  10. 7.2.3 AMP Biotech Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 AMP Biotech Antimicrobial Peptides Product Portfolio
  12. 7.2.5 AMP Biotech Recent Developments
  13. 7.3 Phoenix Biotech
  14. 7.3.1 Phoenix Biotech Company Information
  15. 7.3.2 Phoenix Biotech Business Overview
  16. 7.3.3 Phoenix Biotech Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Phoenix Biotech Antimicrobial Peptides Product Portfolio
  18. 7.3.5 Phoenix Biotech Recent Developments
  19. 7.4 Novabiotics
  20. 7.4.1 Novabiotics Company Information
  21. 7.4.2 Novabiotics Business Overview
  22. 7.4.3 Novabiotics Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Novabiotics Antimicrobial Peptides Product Portfolio
  24. 7.4.5 Novabiotics Recent Developments
  25. 7.5 Chinese Peptide
  26. 7.5.1 Chinese Peptide Company Information
  27. 7.5.2 Chinese Peptide Business Overview
  28. 7.5.3 Chinese Peptide Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Chinese Peptide Antimicrobial Peptides Product Portfolio
  30. 7.5.5 Chinese Peptide Recent Developments
  31. 7.6 Ontores
  32. 7.6.1 Ontores Company Information
  33. 7.6.2 Ontores Business Overview
  34. 7.6.3 Ontores Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Ontores Antimicrobial Peptides Product Portfolio
  36. 7.6.5 Ontores Recent Developments
  37. 7.7 GenScript
  38. 7.7.1 GenScript Company Information
  39. 7.7.2 GenScript Business Overview
  40. 7.7.3 GenScript Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 GenScript Antimicrobial Peptides Product Portfolio
  42. 7.7.5 GenScript Recent Developments
  43. 7.8 Hycult Biotech
  44. 7.8.1 Hycult Biotech Company Information
  45. 7.8.2 Hycult Biotech Business Overview
  46. 7.8.3 Hycult Biotech Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Hycult Biotech Antimicrobial Peptides Product Portfolio
  48. 7.8.5 Hycult Biotech Recent Developments
  49. 7.9 Sunsmile
  50. 7.9.1 Sunsmile Company Information
  51. 7.9.2 Sunsmile Business Overview
  52. 7.9.3 Sunsmile Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Sunsmile Antimicrobial Peptides Product Portfolio
  54. 7.9.5 Sunsmile Recent Developments
  55. 7.10 Ruixing Biotechnology
  56. 7.10.1 Ruixing Biotechnology Company Information
  57. 7.10.2 Ruixing Biotechnology Business Overview
  58. 7.10.3 Ruixing Biotechnology Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Ruixing Biotechnology Antimicrobial Peptides Product Portfolio
  60. 7.10.5 Ruixing Biotechnology Recent Developments
  61. 7.11 Zhongnong Yingtai Biotechnology
  62. 7.11.1 Zhongnong Yingtai Biotechnology Company Information
  63. 7.11.2 Zhongnong Yingtai Biotechnology Business Overview
  64. 7.11.3 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product Portfolio
  66. 7.11.5 Zhongnong Yingtai Biotechnology Recent Developments
  67. 7.12 Glam Technology
  68. 7.12.1 Glam Technology Company Information
  69. 7.12.2 Glam Technology Business Overview
  70. 7.12.3 Glam Technology Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Glam Technology Antimicrobial Peptides Product Portfolio
  72. 7.12.5 Glam Technology Recent Developments
  73. 7.13 ProteLight Pharmaceutical & Biotechnology
  74. 7.13.1 ProteLight Pharmaceutical & Biotechnology Company Information
  75. 7.13.2 ProteLight Pharmaceutical & Biotechnology Business Overview
  76. 7.13.3 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product Portfolio
  78. 7.13.5 ProteLight Pharmaceutical & Biotechnology Recent Developments
8 North America
  1. 8.1 North America Antimicrobial Peptides Market Size by Type
  2. 8.1.1 North America Antimicrobial Peptides Revenue by Type (2021-2032)
  3. 8.1.2 North America Antimicrobial Peptides Sales by Type (2021-2032)
  4. 8.1.3 North America Antimicrobial Peptides Price by Type (2021-2032)
  5. 8.2 North America Antimicrobial Peptides Market Size by Application
  6. 8.2.1 North America Antimicrobial Peptides Revenue by Application (2021-2032)
  7. 8.2.2 North America Antimicrobial Peptides Sales by Application (2021-2032)
  8. 8.2.3 North America Antimicrobial Peptides Price by Application (2021-2032)
  9. 8.3 North America Antimicrobial Peptides Market Size by Country
  10. 8.3.1 North America Antimicrobial Peptides Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Antimicrobial Peptides Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Antimicrobial Peptides Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Antimicrobial Peptides Market Size by Type
  2. 9.1.1 Europe Antimicrobial Peptides Revenue by Type (2021-2032)
  3. 9.1.2 Europe Antimicrobial Peptides Sales by Type (2021-2032)
  4. 9.1.3 Europe Antimicrobial Peptides Price by Type (2021-2032)
  5. 9.2 Europe Antimicrobial Peptides Market Size by Application
  6. 9.2.1 Europe Antimicrobial Peptides Revenue by Application (2021-2032)
  7. 9.2.2 Europe Antimicrobial Peptides Sales by Application (2021-2032)
  8. 9.2.3 Europe Antimicrobial Peptides Price by Application (2021-2032)
  9. 9.3 Europe Antimicrobial Peptides Market Size by Country
  10. 9.3.1 Europe Antimicrobial Peptides Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Antimicrobial Peptides Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Antimicrobial Peptides Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Antimicrobial Peptides Market Size by Type
  2. 10.1.1 China Antimicrobial Peptides Revenue by Type (2021-2032)
  3. 10.1.2 China Antimicrobial Peptides Sales by Type (2021-2032)
  4. 10.1.3 China Antimicrobial Peptides Price by Type (2021-2032)
  5. 10.2 China Antimicrobial Peptides Market Size by Application
  6. 10.2.1 China Antimicrobial Peptides Revenue by Application (2021-2032)
  7. 10.2.2 China Antimicrobial Peptides Sales by Application (2021-2032)
  8. 10.2.3 China Antimicrobial Peptides Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Antimicrobial Peptides Market Size by Type
  2. 11.1.1 Asia Antimicrobial Peptides Revenue by Type (2021-2032)
  3. 11.1.2 Asia Antimicrobial Peptides Sales by Type (2021-2032)
  4. 11.1.3 Asia Antimicrobial Peptides Price by Type (2021-2032)
  5. 11.2 Asia Antimicrobial Peptides Market Size by Application
  6. 11.2.1 Asia Antimicrobial Peptides Revenue by Application (2021-2032)
  7. 11.2.2 Asia Antimicrobial Peptides Sales by Application (2021-2032)
  8. 11.2.3 Asia Antimicrobial Peptides Price by Application (2021-2032)
  9. 11.3 Asia Antimicrobial Peptides Market Size by Country
  10. 11.3.1 Asia Antimicrobial Peptides Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Antimicrobial Peptides Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Antimicrobial Peptides Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Antimicrobial Peptides Market Size by Type
  2. 12.1.1 SAMEA Antimicrobial Peptides Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Antimicrobial Peptides Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Antimicrobial Peptides Price by Type (2021-2032)
  5. 12.2 SAMEA Antimicrobial Peptides Market Size by Application
  6. 12.2.1 SAMEA Antimicrobial Peptides Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Antimicrobial Peptides Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Antimicrobial Peptides Price by Application (2021-2032)
  9. 12.3 SAMEA Antimicrobial Peptides Market Size by Country
  10. 12.3.1 SAMEA Antimicrobial Peptides Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Antimicrobial Peptides Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Antimicrobial Peptides Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Antimicrobial Peptides Value Chain Analysis
  2. 13.1.1 Antimicrobial Peptides Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Antimicrobial Peptides Production Mode & Process
  6. 13.2 Antimicrobial Peptides Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Antimicrobial Peptides Distributors
  9. 13.2.3 Antimicrobial Peptides Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst